Skip to content

Extracorporeal shock wave versus cold therapy for delayed-onset muscle soreness

Extracorporeal shock wave versus cold therapy for delayed-onset muscle soreness

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062257
Enrollment
Unknown
Registered
2022-07-31
Start date
2022-07-30
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delayed onset muscle soreness

Interventions

Experimental group:shockwave treatment

Sponsors

Shenzhen University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. No major underlying diseases; 2. No other discomfort except local muscle soreness and difficulty in moving; 3. Able to fully cooperate with the treatment plan; 4. Characterized by delayed onset muscle pain; 5. Muscle soreness meets the following diagnostic criteria: muscle soreness characterized by delayed onset of unaccustomed training activities or sudden resumption of training after a period of suspension.

Exclusion criteria

Exclusion criteria: 1. Trauma to the painful site or adjacent joint occurred within the last 6 months; 2. Musculoskeletal injury or skin injury at the treatment site; 3. History of autoimmune diseases; 4. Abnormal liver and kidney function; 5. Reduced urine output after exercise; 6. Dark urine; 7. Coagulation dysfunction.

Design outcomes

Primary

MeasureTime frame
Visual analog scale;Rating of perceived exertion;

Countries

China

Contacts

Public ContactDong Jianyang
neuro2015@sina.cn+86 755 21839662

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026